Mysterious child pneumonia cases spike in parts of Europe as COVID-like surge continues in China

Mysterious child pneumonia cases spike in parts of Europe as COVID-like surge continues in China, per NYP.

According to the Netherlands Institute for Health Services Research (NIVEL), last week witnessed an unexpected rise in pneumonia cases, with 80 out of every 100,000 children aged 5 to 15 receiving treatment. Cases among children aged 4 and under also increased from 124 to 145 per 100,000, marking the largest pneumonia outbreak recorded by the Utrecht-based research institute in recent years.

AD_SHOULD_BE_HERE

To provide context, during the peak of the flu season in 2022, there were 60 recorded cases per 100,000 children. Neither NIVEL nor the National Institute for Public Health and the Environment in the Netherlands could offer an explanation for the sudden increase in pneumonia cases among children.

It remains unclear whether this health trend in Europe is linked to the rise in mystery respiratory illnesses in parts of China. The World Health Organization (WHO) and Chinese health officials have stated that no new or unusual pathogens were found in the pneumonia cases. The surge in illnesses in China is attributed to children contracting known viruses, such as the flu, rhinoviruses, respiratory syncytial virus, and adenovirus, which they had avoided during the two years of COVID restrictions. China's strict lockdown rules were lifted at the end of 2022, marking the first post-COVID flu season in the country. Medical experts in China have suggested that a lack of exposure to common viruses during the extended lockdown has weakened the population's immunity.

In the Netherlands, however, COVID-era measures have been lifted for an extended period, raising questions about the factors triggering this new surge in childhood pneumonia cases.

AD_SHOULD_BE_HERE

Unusual Whales does not confirm the information's truthfulness or accuracy of the associated references, data, and cannot verify any of the information. Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Options, investing, trading is risky, and losses are more expected than profits. Please do own research before investing. Please only subscribe after reading our full terms and understanding options and the market, and the inherent risks of trading. It is highly recommended not to trade on this, or any, information from Unusual Whales. Markets are risky, and you will likely lose some or all of your capital. Please check our terms for full details.
Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. See terms for more information.